On October 5, Norton Rose Fulbright’s London office hosted the Annual Regulatory Conference of the Association of British Healthcare Industries (ABHI), which was attended by several hundred compliance and regulatory officers along with in-house counsel from med-tech companies across Europe.
ABHI invited US Head of Life Science and Healthcare Yvonne Puig to deliver the keynote address, “The New Medical Devices Regulation: a View from the US on the New Landscape in the UK”.
London partner Huw Evans introduced Yvonne and also commented on the impact of the new regulatory scheme in a post-Brexit world.
ABHI is the industry association for the medical technology sector in the UK. Led by Yvonne in the US and London partner Milana Chamberlain in the UK, Norton Rose Fulbright has supported ABHI’s expansion efforts for nearly three years and provided ABHI with introductions to leadership in the life sciences and healthcare communities in the US.
On November 9, ABHI and the Dell Medical School at The University of Texas at Austin announced the establishment of the “ABHI Innovation Hub.”
The Hub, a first for ABHI, will offer UK companies the opportunity to locate within a world-class facility and develop their US med-tech business within an ecosystem of clinicians, investors and mentors. It offers companies a compelling office location, providing them the infrastructure to focus on accelerating market access in Texas and across the US.